Recensioni verificate Soddisfatta del servizio.
Personale disponibile e gentile. Lo consiglio a tutti ...
Cliente Sorgente Genetica
logomysorgente

02  4948  5291

  • Cos'è AURORA

    Aurora è il test di screening prenatale di ultima generazione 
    sicuro, affidabile,
    veloce e precoce

  • Sicuro

    Grazie a un semplice prelievo di sangue materno
    eviti il rischio di aborto di tecniche invasive come amniocentesi o villocentesi

  • Affidabile

    Oltre il 99,9% di affidabilità nel rilevare
    la trisomia 21, responsabile
    della Sindrome di Down

  • Precoce e veloce

    icona svegliaIndividuare precocemente la presenza di anomalie cromosomiche è fondamentale:
    puoi effettuare Aurora dalla 10ª settimana

    icona documentoIl test è veloce: risultati in 7-10 giorni lavorativi con la percentuale di test da ripetere più bassa del mercato: 0,1%

  • La serenità della mamma
    in 3 semplici passi

    icotelefona

    Prenota il test

    icoesami

    Fai un prelievo di sangue

    icoginecologo

    Leggi i risultati

  • Test diagnosi prenatale non invasivo
  • 151126 banner Aurora mobile 01
  • 151126 banner Aurora mobile 02
  • 151126 banner Aurora mobile 03
  • slide mobile03
cover cartoon
cover venturetti

Ultime notizie dal mondo della genetica


Neural tube defects also have genetic causes

A team led by the University of Texas is looking for genetic risk factors at the base of neural tube defects. These are common congenital defects, mainly caused by some wrong behavior of the mother. However, the study also proves a strong genetic component.

Prenatal deficiency of folic acid is the most common cause of spina bifida and other neural tube defects. The team of Dr. Hope Northrup also looked for genetic risk factors related to these defects. To this end, the researchers sequenced the genome of 511 individuals with myelomeningoceles, a variant of spina bifida.

Initially, the researchers focused on the variants of more than 100 genes related to neural tube defects. Within the group there were also genes responsible for folate metabolism, glucose homeostasis and other processes. No variant was found to be predominant. Nevertheless, 16% of the subjects showed a large number of suspicious variants in at least one of these genes.

After the initial phase, the researchers compiled a list of the identified variants. This includes more than 5,700 anomalies identified among European patients and almost 8,200 identified among those in Mexico. At this time, they are focusing on 514 new variants not present in existing databases.

According to the authors of the study, the sum of genetic variants could increase exponentially the risk of neural tube defects. Now their goal is to safely identify the genes related to these risk factors. This would allow the development of both new prenatal screening tests and new treatments.

Source: genomeweb.com

Link social

Link social